GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

XRN · Dec 31, 2025

Chiron Real Estate Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001104659-26-021956Reit
Operating-cash-flow growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.operating_cash_flow

5.09% · OPTIONAL · NOT_ENOUGH_HISTORY

DebtRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_debt

$1.2M · CORE · NOT_ENOUGH_HISTORY

Net-income growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.net_income

-202.85% · CORE · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

6.79% · CORE · NOT_ENOUGH_HISTORY

Cash and equivalents100thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.cash

$9.1M · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History9 statesHistory building
Period transition

What moved in the state?

Cash Generation Decreased
Previous
7.75%
Current
5.09%
Delta
-2.67%
Earnings Growth Increased
Previous
-249.16%
Current
-202.85%
Delta
46.31%
Growth Decreased
Previous
8.65%
Current
6.79%
Delta
-1.86%
Liquidity Increased
Previous
$7.1M
Current
$9.1M
Delta
$2.0M
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.